MARKET

SOPH

SOPH

Sophia Genetics Sa
NASDAQ
4.930
-0.330
-6.27%
After Hours: 4.940 +0.01 +0.20% 17:46 03/28 EDT
OPEN
5.21
PREV CLOSE
5.26
HIGH
5.21
LOW
4.930
VOLUME
21.15K
TURNOVER
0
52 WEEK HIGH
7.37
52 WEEK LOW
2.130
MARKET CAP
321.94M
P/E (TTM)
-4.0416
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SOPH last week (0318-0322)?
Weekly Report · 3d ago
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada
Benzinga · 03/20 14:02
12 Health Care Stocks Moving In Monday's After-Market Session
Ontrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. Universe Pharmaceuticals (NASdaq:UPC) shares rose 30.26% in the same session. Augmedix and Sophia Genetics also moved upwards. Losers Acurx Pharmaceuticals, Acutus Medical and Fresh2 Group were among the names in the losers.
Benzinga · 03/18 21:33
Weekly Report: what happened at SOPH last week (0311-0315)?
Weekly Report · 03/18 09:24
SOPHiA Genetics And The French Kidney Cancer Research Network (UroCCR) Publish Results From Multiyear Collaboration On A Study Using A Multimodal Algorithm To Predict Post-operative Outcomes For Those Facing Renal Cell Carcinoma
Benzinga · 03/15 10:08
Weekly Report: what happened at SOPH last week (0304-0308)?
Weekly Report · 03/11 09:23
SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
SOPHiA GENETICS SA (NASDAQ:SOPH) reported revenues of US$62m, in line with expectations. Its shares fell 2.3% in the week after its annual results. Analysts have downgraded their revenue estimates for next year, but the business is expected to grow faster than its industry. The consensus price target for the company remains at US$8.67.
Simply Wall St · 03/09 13:22
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 13, 2024. SOPHiA GENETICS is a cloud-native software company and a leader in data-driven medicine.
Barchart · 03/07 11:07
More
About SOPH
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Webull offers Sophia Genetics SA stock information, including NASDAQ: SOPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SOPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SOPH stock methods without spending real money on the virtual paper trading platform.